{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2017"],"condition":["Multi-disciplinary Treatment","Colorectal Neoplasms"],"data_sharing_plan":["IPD Sharing (as of January 2018): No"],"disease":["Multi-disciplinary Treatment","Colorectal Neoplasms"],"study_type":["Observational"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2263381"],"location":["China"],"study_start_month":["11"],"repository":["ECRIN MDR"],"study_status":["Not provided"],"additional_accession":[]},"is_claimable":false,"name":"MDT to Evaluate the Survival Benefit of Patients With Advanced Gastric / Colorectal Cancer","description":"This is a prospective, multicenter, non-interventional, controlled clinical study. Evaluate MDT performance and benefit analysis in patients with advanced gastric or colorectal cancer after MDT discussion under real medical practice.","dates":{"creation":"2017-11-15"},"accession":"2263381","cross_references":{"ClinicalTrials___gov":["NCT03400657"]}}